Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,338,482−100.0%Sold outHolders
Q1 20261,338,482$19.4M<0.1%+203,843+18.0%AddedHolders
Q4 20251,134,639$16.2M<0.1%+165,117+17.0%AddedHolders
Q3 2025969,522$7.64M<0.1%−213,213−18.0%ReducedHolders
Q2 20251,182,735$6.78M<0.1%+546,637+85.9%AddedHolders
Q1 2025636,098$5.19M<0.1%−28,562−4.3%ReducedHolders
Q4 2024664,660$6.26M<0.1%+32,955+5.2%AddedHolders
Q3 2024631,705$6.75M<0.1%+185,314+41.5%AddedHolders
Q2 2024446,391$4.43M<0.1%+97,454+27.9%AddedHolders
Q1 2024348,937$4.11M<0.1%−378,838−52.1%ReducedHolders
Q4 2023727,775$10.3M<0.1%+315,339+76.5%AddedHolders
Q3 2023412,436$5.02M<0.1%+7,096+1.8%AddedHolders
Q2 2023405,340$5.09M<0.1%−51,810−11.3%ReducedHolders
Q1 2023457,150$5.07M<0.1%+35,330+8.4%AddedHolders
Q4 2022421,820$5.15M<0.1%+16,299+4.0%AddedHolders
Q3 2022405,521$4.23M<0.1%+387,185+2,111.6%AddedHolders
Q2 202218,336$197.0K<0.1%−88,882−82.9%ReducedHolders
Q1 2022107,218$1.01M<0.1%−219,041−67.1%ReducedHolders
Q4 2021326,259$3.77M<0.1%−125,879−27.8%ReducedHolders
Q3 2021452,138$4.32M<0.1%+228,331+102.0%AddedHolders
Q2 2021223,807$2.16M<0.1%−207,946−48.2%ReducedHolders
Q1 2021431,753$4.27M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.